| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Chief Scientific Officer | Restricted Stock Units | 16,650 | $1,524,913 | $57.22 | 11 Feb 2026 | Direct |
| RHYTHM PHARMACEUTICALS, INC. | Chief Scientific Officer | Common Stock | 7,763 | $846,089 | $108.99 | 01 Feb 2026 | Direct |
| RHYTHM PHARMACEUTICALS, INC. | Chief Scientific Officer | Stock Options (Right to Buy) | 25,000 | 11 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 11 Feb 2026 | 2 | $0 | 4 | Chief Scientific Officer | 13 Feb 2026, 17:47 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 01 Feb 2026 | 3 | -$220,814 | 4 | Chief Scientific Officer | 03 Feb 2026, 16:31 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 01 Jul 2025 | 4 | -$85,483 | 4 | Chief Scientific Officer | 03 Jul 2025, 17:12 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 14 Feb 2025 | 2 | $0 | 4 | Chief Scientific Officer | 19 Feb 2025, 21:44 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 08 Jul 2024 | 2 | $0 | 4 | Chief Scientific Officer | 10 Jul 2024, 17:01 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 08 Jul 2024 | 0 | $0 | 3 | Chief Scientific Officer | 10 Jul 2024, 17:00 |